| Viatris Pharma GmbH - Tenofovir Viatris 245 mg, Filmtabletten | | 67014 | | 01 | | Tenofovir Viatris 245 mg | | Filmtabletten | | J05AF07 | | Tenofovir disoproxil | | 24.08.2018 | | |
| | Composition | | tenofovirum disoproxilum 245 mg ut tenofoviri disoproxili maleas, cellulosum microcristallinum, lactosum monohydricum 150 mg, hydroxypropylcellulosum substitutum humile, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum 5.04 mg, triacetinum, E 171, E 132, pro compresso obducto. | | Packungsbestandteile | | Comprimés filmés | | | | | Principe actif | Concentr. |
|---|
| Tenofovir Disoproxil | 245 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Tenofovir Disoproxil | 245 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Cellulosum Microcristallinum | | | | E 132 | | color. | | E 171 | | color. | | Hydroxypropylcellulosum Substitutum Humile | | | | Hypromellosum | | Überzug | | Lactose Monohydrate | 5.04 mg | | | Magnesii Stearas | | | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | | | Triacetinum | | |
| |
| |
|
